ITM in 2020:
- Internationally consolidated the quality, reputation and impact of its programmes in public health within a global alliance of like-minded schools of thought.
- Structurally enhanced its curricula with digital and mixed instruction at the expert and/or master's level in the biomedical and clinical sciences.
- Developed a "Wikitropica" in which it shares and further builds upon its expertise in tropical diseases and public health worldwide.
- Gained innovative insights in the cellular, molecular and environmental biology of Trypanosoma, Leishmania, Plasmodium, helminths, mycobacteria, HIV, tropical viruses.
- Developed innovative diagnostics, treatments or ways of combatting these diseases.
- Built up interdepartmental and interdisciplinary capacity to study and understand infectious epidemics and drug resistance of tropical origin.
- Internationally proven its expertise in the field of clinical trials.
- Produced innovative, impactful contributions for universal health care through empirical and policy-making research, theory building and knowledge management.
- Furthered itself nationally and internationally as an undisputed point of reference in its niche.
- Validated and structured scientific exchange between research and education.
- Consolidated (an) efficient and sustainable business model.
- Brought the partnerships in the South to a level of true equality
- Consolidated these partnerships in terms of scientific contributions with a global impact.
- Renewed cooperation with Flemish knowledge centres.
- Advanced the build-up of an active European network of similar institutions.
- Reformed its support and improvement processes to facilitate the core activities.
- Achieved transparent and robust financial balance.
- Developed talent-oriented personnel policy.
- Maintained up-to-date infrastructure and computer science.
- Built up engaging and unifying communication policy and reputation management.